In this webinar from GEN, The CRISPR Journal, and sponsored by TriLink, Professor Dan Peer will discuss the state of RNA-based therapeutics, particularly developing a self-assembled...
The two companies are collaborating in the development of mRNA vaccines for SARS-CoV-2 and seasonal influenza, but the deal signals Sanofi's desire to advance the mRNA...
- by New Deal democratIt seems pretty clear that Delta burns through the dry tinder very fast - on the order of 9 to 12 weeks...
Translate Bio is partnering with Sanofi in developing MRT5500, an mRNA vaccine based on Translate’s proprietary MRT™ platform, which it acquired from Shire in 2017.
Shares of Autolus Therapeutics were up in trading after the company announced an exclusive licensing agreement with Moderna to develop new messenger RNA therapeutics for cancer.
The COVID-19 pandemic has jumpstarted innovations in viral detection technologies from electrical-based assays to saliva sampling. The post Methods to Detect Viruses Get a Boost, Thanks...
How a team quickly fielded SARS-CoV-2 countermeasures until vaccines were developed. The post Dousing the Pandemic’s Flames appeared first on GEN - Genetic Engineering and Biotechnology...
The expanded EUA also authorizes REGEN-COV for people deemed at high risk of exposure to an infected individual in institutions such as nursing homes or prisons...
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca's shot revealed no serious side effects and no subsequent cases of coronavirus among...
Cell and gene therapies (C&GTs) present opportunities to not only treat disease, but to restore function and improve disease management. Although the opportunities with C&GTs are...
Officials at Cytiva and Pall, part of Danaher, will expand manufacturing capacity and services across geographies for global life sciences customers. A $1.5 billion two-year investment,...
Nanobodies have been developed that can bind and neutralize the SARS-CoV-2 virus up to 1,000 times better than previously developed nanobodies. The new nanobodies are also...
Contrarian investing includes ways to profit from gold for investors willing to consider an asset that has been out of favor in recent times. One hotspot...
While the Delta variant of COVID-19 is getting all the headlines right now, the frontiers of biotechnology are not solely confined to treating the outbreak of...
When three companies emerged in the winter of 2020 promising that a fancy new technology called mRNA could pull the world out of a deadly pandemic,...
While the HIPAA Privacy Rule prevents health care providers from sharing your health information without your permission, it doesn’t prevent other people from asking you about...
In PerkinElmer's largest purchase ever, the Massachusetts-based company is dropping a massive $5.25 billion in cash and stock to buy the biomedical research tool company BioLegend.
Congenica CEO David Atkins recently took time to chat with Clinical OMICs Editor in Chief Chris Anderson about the company’s plans and his views of the...
What are the top NASDAQ genetics stocks year-to-date? We run through the five biggest gainers so far this year. The post Top NASDAQ Genetics Stocks appeared...
The full range of animal species that are susceptible to SARS-CoV-2 infection remains unclear. To fill in some of the gaps, researchers used a repository of...
Six oil investments to buy as the economy improves and energy prices rise are part of an industry that recently led BoA Global Research to forecast...
Expansion plans shared by Regeneron call for the biotech giant to build approximately 900,000 square feet in two phases over six years, consisting of up to...
The rapid increase in demand for mRNA therapeutics has revealed the inherent challenge of the platform—that the production of mRNA is facing a series of bottlenecks....
Scientists collaborate to model the complex protein responsible for SARS-CoV-2 replication, revealing its potential weak spots for drug development Credit: Greg Hura/Berkeley Lab In February 2020,...
The sketchy history of international efforts to control bioweapons suggests that nations will resist cooperative monitoring of gene hacking for medical research.
Here are some of the best biotech stocks worth your attention. The post Top Stocks To Watch This Week? 4 Biotech Stocks To Know appeared first...
New study finds a 17.7 percent rise in COVID-19 cases after a prolonged 2020 wildfire smoke event in Reno, Nev. Credit: U.S. Department of Agriculture Reno,...
Three generic pharmaceutical manufacturers to buy for profitable investing opportunities feature companies that have risen near the top of that sector. The three generic pharmaceutical manufacturers...
Three generic pharmaceutical manufacturers to buy for profitable investing opportunities feature companies that have risen near the top of that sector. The three generic pharmaceutical manufacturers...
A World Health Organization (WHO) committee said on July 12 that human genome editing technologies to treat serious disease should be shared more generously, to allow...